Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy
2016 ◽
Vol 146
(2)
◽
pp. 74-80
◽
2009 ◽
Vol 89
(5)
◽
pp. 577-583
◽
2011 ◽
Vol 52
(12)
◽
pp. 2270-2275
◽
2013 ◽
Vol 55
(3)
◽
pp. 509-514
◽
2016 ◽
Vol 95
(10)
◽
pp. 1661-1669
◽